Novel combination holds potential in treating lung cancer. It also trigger changes to the tumor that enable second therapy to fight the cancer cells.
The first therapy employs suppressed "natural killer" immune cells by extracting them from patients' tumours or blood and supercharging them for three weeks.
The researchers condition the cells by expanding and activating them using tumour-like feeder cells to improve their effectiveness before sending them back into battle against notoriously challenging lung tumors....
Novel combination holds potential in treating lung cancer. It also trigger changes to the tumor that enable second therapy to fight the cancer cells.
The first therapy employs suppressed "natural killer" immune cells by extracting them from patients' tumours or blood and supercharging them for three weeks.
The researchers condition the cells by expanding and activating them using tumour-like feeder cells to improve their effectiveness before sending them back into battle against notoriously challenging lung tumors....